Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
The purpose of this research is to identify a biomarker that is exists when human papillomavirus (HPV) mediated oropharyngeal squamous cell carcinoma is present and does not exist when HPV mediated oropharyngeal squamous cell carcinoma is absent.
Full description
PRIMARY OBJECTIVE:
I. To identify a biomarker (or biomarkers) that is present when disease is present (i.e., at diagnosis or recurrence) and not present when disease is absent (i.e., after treatment, in HPV negative patients or in normal controls).
OUTLINE: This is an observational study.
Patients undergo blood sample collection, saliva sample collection, complete questionnaires and have their medical records reviewed on study.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
* Age ≥ 18 years
Exclusion criteria
* Receiving any other investigational agent which would be considered as a treatment for the primary neoplasm. Patients enrolled in DART are eligible
History of any head and neck malignancy, other than HPV+ oropharyngeal squamous cell carcinoma
Other active malignancy ≤ 5 years prior to registration
180 participants in 1 patient group
Loading...
Central trial contact
Clinical Trials Referral Office
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal